Skip to content
Peptigraph home

Tirzepatide for ADHD: What the Evidence Shows

What human and animal studies show about Tirzepatide for ADHD, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGLP-1 / GIP dual agonistUpdated
Strongest evidence
None graded
no study with an outcome for ADHD (PubMed search, 2 Oct 2026)
Human studies
1
PubMed records, our ledger
Animal studies
0
PubMed records, our ledger

Evidence for ADHD

None of the study abstracts we summarised for Tirzepatide reported an outcome for ADHD (PubMed search, 2 Oct 2026). Claims that it helps with ADHD are unproven.

PubMed records for Tirzepatide and ADHD: 1 human, 0 animal (search counts, not studies we reviewed).

How strong is it?

Strongest evidence:No graded study for ADHD (PubMed search, 2 Oct 2026)

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

ADHD and where tirzepatide enters the picture

On ADHD, MedlinePlus says it is a neurodevelopmental disorder, usually first diagnosed in childhood, that often lasts into adulthood.[16]

A review of binge eating disorder says it is often accompanied by ADHD, and that it is unclear whether tirzepatide and retatrutide help with binge eating and its comorbidities.[17]

The review adds that these drugs have been reported to reduce binge eating in people with obesity or overweight. That is an eating outcome, not an ADHD outcome.[17]

What we could not find

No tirzepatide trial in people with ADHD is cited in this site's evidence file. The nearest psychiatric data come from a post hoc analysis of three SURMOUNT trials in adults with obesity and no known major psychopathology.[18]

That analysis measured depressive symptoms with the PHQ-9 and suicidal ideation and behavior with the C-SSRS.[18]

Other peptides people research for ADHD

All peptides for ADHD, compared

Common questions

Does Tirzepatide help with ADHD?

None of the studies we summarised for Tirzepatide (PubMed search, 2 Oct 2026) measured an outcome for ADHD. Treat claims that it helps with ADHD as unproven.

Is Tirzepatide approved for ADHD?

Tirzepatide is FDA approved (Mounjaro, Zepbound). Which conditions that approval covers is set by the label; use for anything else is off-label.

What is the best peptide for ADHD?

There is no single answer. Our ADHD overview compares each candidate by evidence grade and legal status rather than by popularity.

Can tirzepatide treat ADHD?

There is no evidence that it does; the reviewed literature only notes ADHD as a frequent companion of binge eating disorder.[17]

Does tirzepatide affect ADHD medication?

No interaction with ADHD medicines is described in the sources cited here, so this page cannot say. The Zepbound label guidance cited here concerns oral contraceptives.[19]

More on Tirzepatide

Sources

  1. 1PubMed search: tirzepatide[ti] AND (SURMOUNT[tiab] OR SURPASS[tiab]) AND randomized controlled trial[pt] (93 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  2. 2PubMed search: tirzepatide[ti] AND (SURPASS-2 OR SURPASS-3 OR SURPASS-4 OR SURPASS-5 OR "versus semaglutide" OR "SURPASS-CVOT" OR dulaglutide) (143 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  3. 3PubMed search: tirzepatide[ti] AND (steatohepatitis OR NASH OR "heart failure" OR HFpEF OR "preserved ejection" OR cardiovascular) (410 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  4. 4PubMed search: tirzepatide[ti] AND (SURPASS-2 OR SURPASS-3 OR SURPASS-1 OR SURPASS-5 OR "SURPASS J-mono") AND randomized controlled trial[pt] (24 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  5. 5PubMed search: tirzepatide[ti] AND (steatohepatitis OR "heart failure" OR "SUMMIT" OR "SYNERGY-NASH" OR "phase 2") AND randomized controlled trial[pt] (21 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  6. 6PubMed search: tirzepatide[tiab] AND (meta-analysis[pt] OR systematic review[pt]) AND (weight OR glycemic OR HbA1c OR obesity) (178 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  7. 7PubMed search: tirzepatide[tiab] AND (pharmacokinetic*[tiab] OR half-life[tiab]) AND humans[mh] (49 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  8. 8PubMed search: tirzepatide[ti] AND (insulin degludec OR "SURPASS-3") AND "type 2 diabetes"[ti] AND randomized controlled trial[pt] (8 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  9. 9PubMed search: tirzepatide[ti] AND (cardiovascular outcomes OR "SURPASS-CVOT" OR "major adverse") (228 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  10. 10PubMed search: tirzepatide[tiab] AND (depression OR anxiety OR ADHD OR osteoporosis OR "bone mineral" OR menopause OR "rheumatoid" OR arthritis OR testosterone) (121 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  11. 11PubMed search: tirzepatide[tiab] AND ("body composition"[tiab] OR "lean mass"[tiab] OR "visceral fat"[tiab] OR "fat mass"[tiab]) AND humans[mh] (91 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  12. 12PubMed search: tirzepatide[tiab] AND (blood pressure[tiab] OR cholesterol[tiab] OR lipid*[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt]) (58 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  13. 13PubMed search: tirzepatide[tiab] AND (SURPASS-CVOT OR "cardiovascular events" ) AND "dulaglutide"[tiab] AND randomized controlled trial[pt] (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  14. 14PubMed search: tirzepatide[tiab] AND (depression[tiab] OR anxiety[tiab] OR "mental health"[tiab] OR ADHD[tiab] OR "binge eating"[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt]) (3 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  15. 15PubMed search: tirzepatide[tiab] AND (menopaus*[tiab] OR PCOS[tiab] OR "polycystic"[tiab] OR testosterone[tiab] OR hypogonadism[tiab]) (55 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  16. 16Official web pageOfficial web page · web page
  17. 17Pharmacological Treatment of Binge Eating Disorder and Frequent Comorbid Diseases.CNS drugs · 2024PMID 39096466Accessed 2 Oct 2026
  18. 18Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT.Obesity (Silver Spring, Md.) · 2026PMID 41537305Accessed 2 Oct 2026
  19. 19ZEPBOUND prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026

Found an error? Report a correction.